Top Markets
#1 MowCat MowCat +280.67%
#2 龙虾 (Lobster) 龙虾 (Lobster) +86.75%
#3 Magma Finance Magma Finance +34.73%
#4 Cortex Cortex +26.36%
#5 DeXe DeXe +24.08%
#6 Akedo Akedo +22.69%
#7 SIXSEVEN SIXSEVEN +16.05%
#8 SODAX SODAX +14.20%
#9 OpenEden OpenEden +13.08%
#10 APEX APEX +12.01%
Coin of the day
MowCat MowCat
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Mezzion Pharma Co.,Ltd. Mezzion Pharma Co.,Ltd.

Mezzion Pharma Co.,Ltd.

140410
Kedudukan dalam Saham #7805
Mezzion Pharma Co., Ltd. operates as a pharmaceutical enterprise focused on the... Mezzion Pharma Co., Ltd. operates as a pharmaceutical enterprise focused on the discovery, production, and licensing of various medical treatments. The company's therapeutic offerings target conditions such as erectile dysfunction, benign prostatic hyperplasia, and Fontan disease. Established by Park, Dong-Hyun on September 25, 2002, its corporate base is located in Seoul, South Korea.
Harga Saham
$47.85
Modal Pasaran
$1.45B
Perubahan (1 hari)
4.22%
Perubahan (1 tahun)
63.29%
Negara
KR
Perdagangan Mezzion Pharma Co.,Ltd. (140410)

Kategori

Healthcare
Sejarah hasil dividen untuk Mezzion Pharma Co.,Ltd. (140410)
Hasil dividen (TTM) bagi Mezzion Pharma Co.,Ltd. (simbol saham: 140410) pada 2026 adalah: 0
Purata hasil dividen 5 tahun terakhir: 0.00%
Sejarah hasil dividen untuk Mezzion Pharma Co.,Ltd. (140410) dari 2026 hingga 2026
Hasil dividen pada akhir setiap tahun (TTM)
Tahun Hasil Dividen Ubah
Tidak cukup data untuk tarikh yang disediakan.
Hasil dividen (TTM) untuk syarikat serupa atau pesaing
Syarikat Hasil Dividen Negara
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
1.58%
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
0.00%
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
0.00%
FR
Sino Biopharmaceutical Limited Sino Biopharmaceutical Limited
Sino Biopharmaceutical Limited
1177.HK
2.09%
HK
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
0.00%
IT